PSI CRO Accelerates Deployment of goBalto Platform to Speed Clinical Trials
PSI CRO has chosen goBALTO's suite of SSU applications for all their studies on a worldwide basis to further boost their clinical study startup process. With the use of this new Select application, PSI CRO hopes that it will assist with site identification, feasibility assessment, and selection of investigative sites. Due to the adaption of these new technologies, PSI CRO will be on the right track to success within clinical trials.
Read the full release here.
Driving Diversity with the Integrated Research Model
October 16th 2024Ashley Moultrie, CCRP, senior director, DEI & community engagement, Javara discusses current trends and challenges with achieving greater diversity in clinical trials, how integrated research organizations are bringing care directly to patients, and more.
AI in Clinical Trials: A Long, But Promising Road Ahead
May 29th 2024Stephen Pyke, chief clinical data and digital officer, Parexel, discusses how AI can be used in clinical trials to streamline operational processes, the importance of collaboration and data sharing in advancing the use of technology, and more.
Twice-Yearly Lenacapavir Injections Significantly Reduce HIV Risk, PURPOSE 2 Trial Shows
November 13th 2024Full Phase III PURPOSE 2 trial results suggest that twice-yearly lenacapavir could revolutionize HIV prevention by offering a convenient and effective long-acting option for individuals at risk of infection.
